Modulating gene expression using DNA vaccines with different 3'-UTRs influences antibody titer, seroconversion and cytokine profiles. (Q52949444)

9 May 2018

title

Modulating gene expression using DNA vaccines with different 3'-UTRs influences antibody titer, seroconversion and cytokine profiles. (English)

1 reference

9 May 2018

1 reference

John W Zinckgraf

1

1 reference

9 May 2018

Lawrence K Silbart

series ordinal

2

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 April 2003

1 reference

9 May 2018

published in

Vaccine

1 reference

9 May 2018

volume

21

1 reference

9 May 2018

issue

15

1 reference

9 May 2018

page(s)

1640-1649

1 reference

9 May 2018

Main features of DNA-based immunization vectors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

DNA vaccines: a ray of hope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Optimization of DNA immunization against human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Optimization of plasmid vectors for high-level expression in lung epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Development of improved vectors for DNA-based immunization and other gene therapy applications

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Definition of an efficient synthetic poly(A) site

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

DNA-mediated immunization to hepatitis B virus envelope proteins: preS antigen secretion enhances the humoral response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

The enhancer sequence of human hepatitis B virus can enhance the activity of its surface gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

An improved plasmid DNA expression vector for direct injection into skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Sustained mammary gland-directed, ponasterone A-inducible expression in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Ecdysone-inducible gene expression in mammalian cells and transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Regulation of gene expression in vivo following transduction by two separate rAAV vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Antigen levels and antibody titers after DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

The role of antibody concentration and avidity in antiviral protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900740-5

7 January 2021

10.1016/S0264-410X(02)00740-5

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018